about
Effectiveness of adjunctive antidepressant treatment for bipolar depressionLong-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program.Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Cigarette smoking is associated with suicidality in bipolar disorder.Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.Transition to mania during treatment of bipolar depressionAn exploratory study of responses to low-dose lithium in African Americans and Hispanics.Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation TrialStratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study.Stability of symptoms across major depressive episodes in bipolar disorderA randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.Sleep disturbance in euthymic bipolar patients.General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.Suicidal ideation and depressive symptoms among bipolar patients as predictors of the health and well-being of caregivers.Medication adherence in a comparative effectiveness trial for bipolar disorder.Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.A critical review of pharmacotherapy for major depressive disorder.Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).Alcohol and the law.Controversies in the psychopharmacology of bipolar disorder.A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants.Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research.Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.Association between borderline personality structure and history of childhood abuse in adult volunteers.Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.
P50
Q28295408-66D50CC7-1836-4B69-9D10-3CE4AAC3E4F5Q30925648-6A7D6FAE-5E6C-4C1F-9973-144B1620ADBAQ30991875-E0E51E01-A12E-41D4-B372-D166357DF065Q31005227-BCF32BA9-32E0-4BE9-A4F6-1FE15BBD2DA0Q31036087-095129AF-C379-4797-BD41-2316377D19E2Q33518341-A3ACDBC9-4D12-44B8-ADEB-D917A06AE14FQ34052212-0901A563-AC49-4A57-8942-9F49F981D4C7Q34564599-EC9374ED-74B1-48F1-BEEB-8D049307CF31Q34582156-8FD7390C-3870-483E-A00B-FAADBEC186E4Q34616063-F4A63C66-E262-424B-9D4A-BD53C967F358Q34661431-4F53A6C5-C8E2-4EFA-8D58-5AEE5A2AD10FQ35428586-A5EB2D47-4DC3-4302-A680-D64359E39716Q35901154-69C53503-B8FE-493F-9B62-F48B85EDCF5FQ36005762-DDF620A9-F150-4BAF-9E65-DC488BB89BE4Q36565679-9B19311E-002C-404A-9958-5423F5F6F6D3Q36593276-AFE53636-E1EF-41A8-A0D3-A0495448D9ECQ36685249-BF1324EF-48FC-45E7-912A-DD0199AD75EFQ36760619-B6E63BC6-E26F-40AF-8D5A-9F8F91FB2FC1Q37209047-7D91ADDA-C564-40A1-8734-F383EF4652F4Q37213547-63FD88AF-408B-4A32-B36F-26D2779DEFA6Q37224904-E8263C5E-7CEC-46EE-AA16-D098A23E2951Q37485731-28D9D269-83E0-4823-86E9-82EEB61EFE96Q37684910-0147FE06-FE8B-45C5-AF48-F281D1F2BC14Q37712537-D96FA351-853E-4693-8B02-32DF4ACAAC62Q37846892-F130C08C-971A-4C8B-A3A7-C5EF964931F3Q37954411-5C12D4F9-FB72-40C8-AC69-8620088B9BCFQ38259392-4B90827C-4282-4462-B973-BAC364FF3A1EQ38282248-18E08C4F-033F-4BB1-BCCF-AE13305DF9BDQ38952459-EF2096FB-A385-4327-81D8-60C744C14721Q39344604-75F62E42-DA77-40A7-8C13-131A7F71FE70Q42638564-CC38036C-4A5A-45A9-B357-38C1F93AD554Q42640514-B8C7E503-7670-408C-BA45-5D1EAF92E373Q42661794-A6EDEEFA-1397-4E55-A8BD-30C9129F8076Q43120870-EBF14A2E-AD07-4652-8654-CEA086776CBBQ43145921-786F1EC7-6B50-451E-B575-F1F053666687Q43624073-EF6BA4A0-2E06-4820-A98C-E49D488CE8E5Q43656660-86994DDF-0541-4E43-AB7F-F8FD0CDD264FQ44541026-6F9C69C0-D2F5-47BA-A741-72882F87E2A0Q45053879-5EEE5207-4D49-4E2B-8127-00CFBC745114Q45912017-DFE4D587-AC97-4C03-B990-64570DD6A6F4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael J. Ostacher
@ast
Michael J. Ostacher
@en
Michael J. Ostacher
@es
Michael J. Ostacher
@nl
Michael J. Ostacher
@sl
type
label
Michael J. Ostacher
@ast
Michael J. Ostacher
@en
Michael J. Ostacher
@es
Michael J. Ostacher
@nl
Michael J. Ostacher
@sl
prefLabel
Michael J. Ostacher
@ast
Michael J. Ostacher
@en
Michael J. Ostacher
@es
Michael J. Ostacher
@nl
Michael J. Ostacher
@sl
P106
P1153
6508100126
P21
P31
P496
0000-0003-0353-7535